Fermina M. Mazzella

579 total citations
18 papers, 387 citations indexed

About

Fermina M. Mazzella is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Fermina M. Mazzella has authored 18 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Fermina M. Mazzella's work include Acute Myeloid Leukemia Research (6 papers), Hemoglobinopathies and Related Disorders (4 papers) and Hematological disorders and diagnostics (3 papers). Fermina M. Mazzella is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hemoglobinopathies and Related Disorders (4 papers) and Hematological disorders and diagnostics (3 papers). Fermina M. Mazzella collaborates with scholars based in United States, Italy and Austria. Fermina M. Mazzella's co-authors include Harold R. Schumacher, Areta Kowal-Vern, James T. Rector, James D. Cotelingam, Steven Sieber, David H. Munn, Jeffrey R. Lee, Scott Antonia, Russell Burgess and Jane L. Messina and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Human Pathology.

In The Last Decade

Fermina M. Mazzella

17 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fermina M. Mazzella United States	11	130	116	100	78	66	18	387
A. Degrassi Italy	13	108 0.8×	83 0.7×	69 0.7×	124 1.6×	5 0.1×	37	403
Christina Kober Germany	10	35 0.3×	96 0.8×	18 0.2×	50 0.6×	30 0.5×	13	238
Julia J.M. Eekels Netherlands	11	60 0.5×	155 1.3×	18 0.2×	27 0.3×	36 0.5×	14	280
Cécile Le Saout United States	10	14 0.1×	63 0.5×	34 0.3×	224 2.9×	22 0.3×	12	355
Eduard Schulz United States	10	145 1.1×	118 1.0×	54 0.5×	31 0.4×	44 0.7×	44	437
Kevin Hadi United States	4	27 0.2×	76 0.7×	16 0.2×	191 2.4×	25 0.4×	7	344
Gilles Iserentant Luxembourg	7	47 0.4×	62 0.5×	12 0.1×	372 4.8×	13 0.2×	11	464
John H. Gallo Australia	10	62 0.5×	67 0.6×	47 0.5×	54 0.7×	15 0.2×	15	348
MA Brach Germany	4	64 0.5×	152 1.3×	16 0.2×	275 3.5×	28 0.4×	7	430
Yoko Mizoguchi Japan	12	48 0.4×	64 0.6×	20 0.2×	158 2.0×	13 0.2×	35	327

Countries citing papers authored by Fermina M. Mazzella

Since Specialization

Citations

This map shows the geographic impact of Fermina M. Mazzella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fermina M. Mazzella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fermina M. Mazzella more than expected).

Fields of papers citing papers by Fermina M. Mazzella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fermina M. Mazzella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fermina M. Mazzella. The network helps show where Fermina M. Mazzella may publish in the future.

Co-authorship network of co-authors of Fermina M. Mazzella

This figure shows the co-authorship network connecting the top 25 collaborators of Fermina M. Mazzella. A scholar is included among the top collaborators of Fermina M. Mazzella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fermina M. Mazzella. Fermina M. Mazzella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Mazzella, Fermina M., Yaxia Zhang, & Thomas W. Bauer. (2024). Update on the role of pathology and laboratory medicine in diagnosing periprosthetic infection. Human Pathology. 147. 5–14. 2 indexed citations

Feldman, Tatyana, Kar Fai Chow, Anthony R. Mato, et al.. (2013). PEG-Asparaginase Based Multidrug Chemotherapy is Effective for Refractory Disseminated Extranodal NK/T-Cell Lymphoma With Leptomentigeal Involvement: A Clinical Case Report and Review of Literature. 2(1). 31–36. 1 indexed citations

Banada, Padmapriya P., et al.. (2012). Highly Sensitive Detection of Staphylococcus aureus Directly from Patient Blood. PLoS ONE. 7(2). e31126–e31126. 43 indexed citations

Kasar, Siddha, Erica Salerno, Yuan Yao, et al.. (2011). Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia. Genes and Immunity. 13(2). 109–119. 59 indexed citations

Salerno, Erica, Yuan Yao, Brian J. Scaglione, et al.. (2010). The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Cytometry Part B Clinical Cytometry. 78B(S1). S98–109. 10 indexed citations

Mazzella, Fermina M., David A. Smith, Paul S. Horn, et al.. (2006). Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients. American Journal of Hematology. 81(7). 484–491. 13 indexed citations

Kulharya, Anita S., et al.. (2006). Granular Acute Lymphoblastic Leukemia in Adults: Report of a Case and Review of the Literature. Southern Medical Journal. 99(8). 894–897. 3 indexed citations

Lee, Jeffrey R., Rory R. Dalton, Jane L. Messina, et al.. (2003). Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma. Laboratory Investigation. 83(10). 1457–1466. 88 indexed citations

Schumacher, Harold R., et al.. (2002). Acute leukemia. Clinics in Laboratory Medicine. 22(1). 153–192. 6 indexed citations

10.

Kowal-Vern, Areta, et al.. (2000). Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases. American Journal of Hematology. 65(1). 5–13. 41 indexed citations

11.

Mazzella, Fermina M., et al.. (2000). Effects of Multidrug Resistance Gene Expression in Acute Erythroleukemia. Modern Pathology. 13(4). 407–413. 12 indexed citations

12.

Mazzella, Fermina M., et al.. (2000). The Acute Erythroleukemias. Clinics in Laboratory Medicine. 20(1). 119–137. 20 indexed citations

13.

Mazzella, Fermina M. & Harold R. Schumacher. (2000). Acute Erythroleukemia, M6b. Archives of Pathology & Laboratory Medicine. 124(2). 330–331. 3 indexed citations

14.

Mazzella, Fermina M., Areta Kowal-Vern, James T. Rector, et al.. (1998). Acute Erythroleukemia: Evaluation of 48 Cases With Reference to Classification, Cell Proliferation, Cytogenetics, and Prognosis. American Journal of Clinical Pathology. 110(5). 590–598. 42 indexed citations

15.

Mazzella, Fermina M., et al.. (1996). A case of concurrent presentation of human ehrlichiosis and Lyme disease in Connecticut.. PubMed. 60(9). 515–9. 6 indexed citations

16.

Mazzella, Fermina M., et al.. (1995). Ductal carcinoma of male breast with prominent lipid-rich component. Pathology. 27(3). 280–283. 26 indexed citations

17.

Mazzella, Fermina M., et al.. (1995). Histiocytoid Hemangioma of the Testis. The Journal of Urology. 743–744.

18.

Mazzella, Fermina M., et al.. (1995). Histiocytoid Hemangioma of the Testis: A Case Report. The Journal of Urology. 153(3). 743–744. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact